Abigail L. Jenkins

Insider Reports History

Location
Boston, MA
Signature
/s/ Lori Braender, as Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Abigail L. Jenkins:

Company Role Class Num Shares Value Price $ Report Date Ownership
Gamida Cell Ltd. President and CEO, Director Ordinary Shares 375,142 $581,470 $1.55 19 Oct 2023 Direct
Aquestive Therapeutics, Inc. Director Non-Qualified Stock Option (right to buy) 42,000 $143,220 $3.41 11 Jun 2025 Direct
Gamida Cell Ltd. President and CEO, Director Employee Share Option (Right to Buy) 217,954 19 Oct 2023 Direct

Insider Reports Filed by Abigail L. Jenkins

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AQST Aquestive Therapeutics, Inc. 11 Jun 2025 1 -$143,220 4 Director 12 Jun 2025, 13:59
AQST Aquestive Therapeutics, Inc. 10 May 2024 1 $0 4 Director 13 May 2024, 13:40
AQST Aquestive Therapeutics, Inc. 01 Apr 2024 0 $0 3 Director 26 Apr 2024, 09:20
/report/000120919123053269-jenkins-abigail-l-2023-10-19 Gamida Cell Ltd. 19 Oct 2023 2 $0 4 President and CEO, Director 20 Oct 2023, 16:40
/report/000120919123053258-jenkins-abigail-l-2023-10-19-restatement Gamida Cell Ltd. 19 Oct 2023 2 $0 4/A President and CEO, Director 20 Oct 2023, 16:34
/report/000120919122052218-jenkins-abigail-l-2022-09-30 Gamida Cell Ltd. 30 Sep 2022 1 +$25,000 4 President and CEO, Director 04 Oct 2022, 16:19
/report/000120919122050708-jenkins-abigail-l-2022-09-19 Gamida Cell Ltd. 19 Sep 2022 2 $0 4 President and CEO, Director 20 Sep 2022, 16:10
/report/000120919122050699-jenkins-abigail-l-2022-09-19 Gamida Cell Ltd. 19 Sep 2022 0 $0 3 President and CEO, Director 20 Sep 2022, 16:07